{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T23:24:21Z","timestamp":1794525861921,"version":"4.9.1"},"reference-count":169,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:00:00Z","timestamp":1778630400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.biopha.2026.119534","type":"journal-article","created":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T22:54:12Z","timestamp":1780008852000},"page":"119534","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Distinctive characteristics of dopamine neuron release mechanisms: Insights into Parkinson\u2019s Disease"],"prefix":"10.1016","volume":"200","author":[{"given":"Emanuele Di","family":"Martino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarinah","family":"Maduro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Luchicchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micha M.M.","family":"Wilhelmus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola Salvatore","family":"Orefice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2026.119534_bib1","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1186\/s12889-025-23492-8","article-title":"The global, regional, and National burden of parkinson\u2019s disease in 204 countries and territories, 1990\u20132021: a systematic analysis for the global burden of disease study 2021","volume":"25","author":"Li","year":"2025","journal-title":"BMC Public Health"},{"key":"10.1016\/j.biopha.2026.119534_bib2","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S1474-4422(18)30295-3","article-title":"Global, regional, and national burden of Parkinson\u2019s disease, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016","volume":"17","author":"Dorsey","year":"2018","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.biopha.2026.119534_bib3","first-page":"S3","article-title":"The emerging evidence of the Parkinson Pandemic","volume":"8","author":"Dorsey","year":"2018","journal-title":"J. Park. Dis."},{"key":"10.1016\/j.biopha.2026.119534_bib4","doi-asserted-by":"crossref","first-page":"259","DOI":"10.3988\/jcn.2022.18.3.259","article-title":"Clinical aspects of the differential diagnosis of Parkinson\u2019s disease and Parkinsonism","volume":"18","author":"Shin","year":"2022","journal-title":"J. Clin. Neurol."},{"key":"10.1016\/j.biopha.2026.119534_bib5","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S1474-4422(06)70373-8","article-title":"Non-motor symptoms of Parkinson\u2019s disease: diagnosis and management","volume":"5","author":"Chaudhuri","year":"2006","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.biopha.2026.119534_bib6","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","article-title":"Parkinson\u2019s disease","volume":"386","author":"Kalia","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2026.119534_bib7","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1007\/s00415-021-10443-7","article-title":"Contribution of neuropsychiatric symptoms in Parkinson\u2019s disease to different domains of caregiver burden","volume":"268","author":"Chahine","year":"2021","journal-title":"J. Neurol."},{"key":"10.1016\/j.biopha.2026.119534_bib8","first-page":"541","article-title":"Impact of neuropsychiatric symptoms on the quality of life of subjects with Parkinson\u2019s Disease","volume":"5","author":"Alvarado-Bola\u00f1os","year":"2015","journal-title":"J. Park. Dis."},{"key":"10.1016\/j.biopha.2026.119534_bib9","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s11910-013-0409-5","article-title":"Depression and Parkinson\u2019s disease: current knowledge","volume":"13","author":"Marsh","year":"2013","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"10.1016\/j.biopha.2026.119534_bib10","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0896-6273(03)00568-3","article-title":"Parkinson\u2019s disease","volume":"39","author":"Dauer","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.biopha.2026.119534_bib11","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1002\/mds.29269","article-title":"Morpho-functional changes of nigral dopamine neurons in an \u03b1-synuclein model of Parkinson\u2019s Disease","volume":"38","author":"Ledonne","year":"2023","journal-title":"Mov. Disord."},{"key":"10.1016\/j.biopha.2026.119534_bib12","series-title":"International Review of Neurobiology","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/bs.irn.2017.01.008","article-title":"The new diagnostic criteria for Parkinson\u2019s Disease","author":"Postuma","year":"2017"},{"key":"10.1016\/j.biopha.2026.119534_bib13","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.autrev.2016.07.022","article-title":"Parkinson\u2019s disease: autoimmunity and neuroinflammation","volume":"15","author":"De Virgilio","year":"2016","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.biopha.2026.119534_bib14","first-page":"27","article-title":"Overview of Parkinson\u2019s disease","author":"Lew","year":"2007","journal-title":"Pharmacother. J. Hum. Pharmacol. Drug Ther."},{"key":"10.1016\/j.biopha.2026.119534_bib15","doi-asserted-by":"crossref","first-page":"717","DOI":"10.3109\/00207454.2014.982795","article-title":"Neuroinflammation in Parkinson\u2019s disease: role in neurodegeneration and tissue repair","volume":"125","author":"Vivekanantham","year":"2015","journal-title":"Int. J. Neurosci."},{"key":"10.1016\/j.biopha.2026.119534_bib16","first-page":"1","article-title":"Evidence of inflammatory system involvement in Parkinson\u2019s Disease","volume":"2014","author":"Chao","year":"2014","journal-title":"BioMed. Res. Int."},{"key":"10.1016\/j.biopha.2026.119534_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0128651","article-title":"Evidence for immune response, axonal dysfunction and reduced endocytosis in the substantia nigra in early stage Parkinson\u2019s Disease","volume":"10","author":"Dijkstra","year":"2015","journal-title":"PLOS ONE"},{"key":"10.1016\/j.biopha.2026.119534_bib18","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/mds.27874","article-title":"Targeting the microglial NLRP3 inflammasome and its role in Parkinson\u2019s Disease","volume":"35","author":"Haque","year":"2020","journal-title":"Mov. Disord."},{"key":"10.1016\/j.biopha.2026.119534_bib19","series-title":"Handbook of Neurochemistry and Molecular Neurobiology","first-page":"149","article-title":"Dopamine and the Dopaminergic Systems of the Brain","author":"Harsing","year":"2008"},{"key":"10.1016\/j.biopha.2026.119534_bib20","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s10571-018-0632-3","article-title":"Dopamine: functions, signaling, and association with neurological diseases","volume":"39","author":"Klein","year":"2019","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.biopha.2026.119534_bib21","doi-asserted-by":"crossref","first-page":"2910","DOI":"10.1016\/S0021-9258(18)93832-9","article-title":"Tyrosine hydroxylase","volume":"239","author":"Nagatsu","year":"1964","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2026.119534_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.abb.2010.12.017","article-title":"Tyrosine hydroxylase and regulation of dopamine synthesis","volume":"508","author":"Daubner","year":"2011","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.biopha.2026.119534_bib23","doi-asserted-by":"crossref","first-page":"779","DOI":"10.3390\/brainsci12060779","article-title":"Changes in tyrosine hydroxylase activity and dopamine synthesis in the nigrostriatal system of mice in an acute model of Parkinson\u2019s Disease as a Manifestation of Neurodegeneration and Neuroplasticity","volume":"12","author":"Kolacheva","year":"2022","journal-title":"Brain Sci."},{"key":"10.1016\/j.biopha.2026.119534_bib24","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1056\/NEJM197208032870508","article-title":"Catecholamines","volume":"287","author":"Axelrod","year":"1972","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biopha.2026.119534_bib25","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1042\/BST20231061","article-title":"Dopamine synthesis and transport: current and novel therapeutics for parkinsonisms","volume":"52","author":"Tai","year":"2024","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.biopha.2026.119534_bib26","doi-asserted-by":"crossref","first-page":"5401","DOI":"10.1021\/bi200733c","article-title":"Identification of phenylalanine 3-hydroxylase for meta -tyrosine biosynthesis","volume":"50","author":"Zhang","year":"2011","journal-title":"Biochemistry"},{"key":"10.1016\/j.biopha.2026.119534_bib27","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/iub.1150","article-title":"Phenylalanine hydroxylase: Function, structure, and regulation","volume":"65","author":"Flydal","year":"2013","journal-title":"IUBMB Life"},{"key":"10.1016\/j.biopha.2026.119534_bib28","series-title":"Advances in Pharmacology","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/B978-0-12-411512-5.00002-6","article-title":"Tyrosine hydroxylase","author":"Dickson","year":"2013"},{"key":"10.1016\/j.biopha.2026.119534_bib29","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1111\/j.1471-4159.2004.02797.x","article-title":"Tyrosine hydroxylase phosphorylation: regulation and consequences","volume":"91","author":"Dunkley","year":"2004","journal-title":"J. Neurochem."},{"key":"10.1016\/j.biopha.2026.119534_bib30","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1111\/jnc.14675","article-title":"Tyrosine hydroxylase phosphorylation","volume":"149","author":"Dunkley","year":"2019","journal-title":"vivo. J. Neurochem."},{"key":"10.1016\/j.biopha.2026.119534_bib31","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1006\/exnr.1996.6379","article-title":"Dopamine synthesis, uptake, metabolism, and receptors: relevance to gene therapy of Parkinson\u2019s Disease","volume":"144","author":"Elsworth","year":"1997","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.biopha.2026.119534_bib32","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.tibs.2019.12.007","article-title":"Structure and roles of V-type ATPases","volume":"45","author":"Vasanthakumar","year":"2020","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.biopha.2026.119534_bib33","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/28190","article-title":"Visualizing secretion and synaptic transmission with pH-sensitive green fluorescent proteins","volume":"394","author":"Miesenb\u00f6ck","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2026.119534_bib34","first-page":"1","article-title":"Dopamine oxidation and autophagy","volume":"2012","author":"Mu\u00f1oz","year":"2012","journal-title":"Park. Dis."},{"key":"10.1016\/j.biopha.2026.119534_bib35","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/BF03033289","article-title":"Intraneuronal dopamine-quinone synthesis: a review","volume":"1","author":"Sulzer","year":"1999","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.biopha.2026.119534_bib36","doi-asserted-by":"crossref","first-page":"467","DOI":"10.3389\/fnmol.2018.00467","article-title":"Dopamine autoxidation is controlled by acidic pH","volume":"11","author":"Umek","year":"2018","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.biopha.2026.119534_bib37","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/s41422-023-00906-z","article-title":"Transport and inhibition mechanism for VMAT2-mediated synaptic vesicle loading of monoamines","volume":"34","author":"Wang","year":"2024","journal-title":"Cell Res"},{"key":"10.1016\/j.biopha.2026.119534_bib38","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.neuint.2013.12.003","article-title":"The vesicular monoamine transporter 2: an underexplored pharmacological target","volume":"73","author":"Bernstein","year":"2014","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.biopha.2026.119534_bib39","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1038\/nrn983","article-title":"Pathogenesis of parkinson\u2019s disease: dopamine, vesicles and \u03b1-synuclein","volume":"3","author":"Lotharius","year":"2002","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.biopha.2026.119534_bib40","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/j.1471-4159.2007.05108.x","article-title":"VMAT2 and dopamine neuron loss in a primate model of Parkinson\u2019s disease","volume":"105","author":"Chen","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.biopha.2026.119534_bib41","doi-asserted-by":"crossref","first-page":"7212","DOI":"10.1523\/JNEUROSCI.0711-11.2011","article-title":"The Parkinsonian mimetic, MPP+, specifically impairs mitochondrial transport in dopamine axons","volume":"31","author":"Kim-Han","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.biopha.2026.119534_bib42","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1007\/s11064-015-1574-5","article-title":"Volume transmission in central dopamine and noradrenaline neurons and its astroglial targets","volume":"40","author":"Fuxe","year":"2015","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.biopha.2026.119534_bib43","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/s41583-021-00455-7","article-title":"Spatial and temporal scales of dopamine transmission","volume":"22","author":"Liu","year":"2021","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.biopha.2026.119534_bib44","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.neuron.2014.08.058","article-title":"Phasic dopamine release drives rapid activation of striatal D2-Receptors","volume":"84","author":"Marcott","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/j.biopha.2026.119534_bib45","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/nn.4252","article-title":"Fluorescent false neurotransmitter reveals functionally silent dopamine vesicle clusters in the striatum","volume":"19","author":"Pereira","year":"2016","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.biopha.2026.119534_bib46","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1073\/pnas.1213569110","article-title":"Fluorescent dopamine tracer resolves individual dopaminergic synapses and their activity in the brain","volume":"110","author":"Rodriguez","year":"2013","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.biopha.2026.119534_bib47","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202511186","article-title":"SPLICEIT fluorescent sensor for integrating dopamine release with cellular resolution","volume":"64","author":"Havens","year":"2025","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.biopha.2026.119534_bib48","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.neuron.2017.10.006","article-title":"Transcellular nanoalignment of synaptic function","volume":"96","author":"Biederer","year":"2017","journal-title":"Neuron"},{"key":"10.1016\/j.biopha.2026.119534_bib49","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.neuron.2021.10.028","article-title":"Molecular and functional architecture of striatal dopamine release sites","volume":"110","author":"Banerjee","year":"2022","journal-title":"Neuron"},{"key":"10.1016\/j.biopha.2026.119534_bib50","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.58359","article-title":"Synaptotagmin-1 is the Ca2+ sensor for fast striatal dopamine release","volume":"9","author":"Banerjee","year":"2020","journal-title":"eLife"},{"key":"10.1016\/j.biopha.2026.119534_bib51","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1136\/jnnp-2017-315922","article-title":"Insights into Parkinson\u2019s disease from computational models of the basal ganglia","volume":"89","author":"Humphries","year":"2018","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.biopha.2026.119534_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112231","article-title":"Dopamine transporter and synaptic vesicle sorting defects underlie auxilin-associated Parkinson\u2019s disease","volume":"42","author":"Vidyadhara","year":"2023","journal-title":"Cell Rep."},{"key":"10.1016\/j.biopha.2026.119534_bib53","doi-asserted-by":"crossref","DOI":"10.3389\/fnint.2021.619160","article-title":"Dysfunction of synaptic vesicle endocytosis in Parkinson\u2019s Disease","volume":"15","author":"Zou","year":"2021","journal-title":"Front. Integr. Neurosci."},{"key":"10.1016\/j.biopha.2026.119534_bib54","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.4103\/NRR.NRR-D-23-01624","article-title":"Dysfunction of synaptic endocytic trafficking in Parkinson\u2019s disease","volume":"19","author":"Ng","year":"2024","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.biopha.2026.119534_bib55","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1002\/mds.27614","article-title":"The endocytic membrane trafficking pathway plays a major role in the risk of Parkinson\u2019s disease","volume":"34","author":"Bandres-Ciga","year":"2019","journal-title":"Mov. Disord."},{"key":"10.1016\/j.biopha.2026.119534_bib56","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.1093\/brain\/awad064","article-title":"Impaired dopamine release in Parkinson\u2019s disease","volume":"146","author":"Cramb","year":"2023","journal-title":"Brain"},{"key":"10.1016\/j.biopha.2026.119534_bib57","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/nn0404-321","article-title":"Synaptic vesicles really do kiss and run","volume":"7","author":"Wightman","year":"2004","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.biopha.2026.119534_bib58","first-page":"10","article-title":"Molecular mechanisms for the coupling of endocytosis to exocytosis in neurons","author":"Xie","year":"2017","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.biopha.2026.119534_bib59","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1038\/s41556-024-01499-4","article-title":"Clathrin-associated carriers enable recycling through a kiss-and-run mechanism","volume":"26","author":"Xu","year":"2024","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.biopha.2026.119534_bib60","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.neuint.2018.11.004","article-title":"Presynaptic regulation of dopamine release: role of the DAT and VMAT2 transporters","volume":"122","author":"Mulvihill","year":"2019","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.biopha.2026.119534_bib61","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.tips.2013.07.005","article-title":"Mechanisms of dopamine transporter regulation in normal and disease states","volume":"34","author":"Vaughan","year":"2013","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.biopha.2026.119534_bib62","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3181\/00379727-78-19006","article-title":"Metabolism of Amines. II: mitochondrial localization of monoamine oxidase","volume":"78","author":"Cotzias","year":"1951","journal-title":"Exp. Biol. Med."},{"key":"10.1016\/j.biopha.2026.119534_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2024.115410","article-title":"Effects of MAO\u2011B inhibitors in life quality of Parkinson\u2019s disease patients: A systematic review and meta\u2011analysis","volume":"480","author":"Liu","year":"2025","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.biopha.2026.119534_bib64","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/WNF.0000000000000239","article-title":"A randomized double-blind placebo-controlled phase III trial of selegiline monotherapy for early Parkinson disease","volume":"40","author":"Mizuno","year":"2017","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.biopha.2026.119534_bib65","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1212\/01.wnl.0000204007.46190.54","article-title":"Selegiline slows the progression of the symptoms of Parkinson disease","volume":"66","author":"P\u00e5lhagen","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.biopha.2026.119534_bib66","doi-asserted-by":"crossref","unstructured":"Tan, Y.-Y., Jenner, P., Chen, S.-D., 2022. Monoamine Oxidase-B Inhibitors for the Treatment of Parkinson\u2019s Disease: Past, Present, and Future. J. Park. Dis. 12, 477\u2013493. https:\/\/doi.org\/10.3233\/JPD-212976.","DOI":"10.3233\/JPD-212976"},{"key":"10.1016\/j.biopha.2026.119534_bib67","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/265080a0","article-title":"Dopamine is a monoamine oxidase B substrate in man","volume":"265","author":"Glover","year":"1977","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2026.119534_bib68","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s00702-022-02465-w","article-title":"A critical appraisal of MAO-B inhibitors in the treatment of Parkinson\u2019s disease","volume":"129","author":"Jost","year":"2022","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.biopha.2026.119534_bib69","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1080\/03602532.2018.1555587","article-title":"Aldehyde toxicity and metabolism: the role of aldehyde dehydrogenases in detoxification, drug resistance and carcinogenesis","volume":"51","author":"Ahmed Laskar","year":"2019","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.biopha.2026.119534_bib70","series-title":"Comprehensive Toxicology","first-page":"1","article-title":"General Overview of Toxicology","author":"Eaton","year":"2018"},{"key":"10.1016\/j.biopha.2026.119534_bib71","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/0165-1218(91)90128-9","article-title":"Aldehydes: occurrence, carcinogenic potential, mechanism of action and risk assessment","volume":"259","author":"Feron","year":"1991","journal-title":"Mutat. Res. Toxicol."},{"key":"10.1016\/j.biopha.2026.119534_bib72","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.pharmthera.2014.06.006","article-title":"Catecholamine autotoxicity. Implications for pharmacology and therapeutics of Parkinson disease and related disorders","volume":"144","author":"Goldstein","year":"2014","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.biopha.2026.119534_bib73","doi-asserted-by":"crossref","first-page":"26978","DOI":"10.1074\/jbc.M111.249532","article-title":"Oxidation of 3,4-dihydroxyphenylacetaldehyde, a toxic dopaminergic metabolite, to a semiquinone radical and an ortho-quinone","volume":"286","author":"Anderson","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2026.119534_bib74","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/1055-8330(95)90016-0","article-title":"An endogenous dopaminergic neurotoxin: Implication for Parkinson\u2019s disease","volume":"4","author":"Mattammal","year":"1995","journal-title":"Neurodegeneration"},{"key":"10.1016\/j.biopha.2026.119534_bib75","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202301253R","article-title":"Prodromal Parkinson\u2019s disease and the catecholaldehyde hypothesis: insight from olfactory bulb organotypic cultures","volume":"37","author":"Bagnoli","year":"2023","journal-title":"FASEB J."},{"key":"10.1016\/j.biopha.2026.119534_bib76","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1021\/tx5002223","article-title":"Benomyl, aldehyde dehydrogenase, DOPAL, and the catecholaldehyde hypothesis for the pathogenesis of Parkinson\u2019s Disease","volume":"27","author":"Casida","year":"2014","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.biopha.2026.119534_bib77","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1212\/WNL.0000000000000083","article-title":"Aldehyde dehydrogenase variation enhances effect of pesticides associated with Parkinson disease","volume":"82","author":"Fitzmaurice","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.biopha.2026.119534_bib78","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1073\/pnas.1220399110","article-title":"Aldehyde dehydrogenase inhibition as a pathogenic mechanism in Parkinson disease","volume":"110","author":"Fitzmaurice","year":"2013","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.biopha.2026.119534_bib79","doi-asserted-by":"crossref","first-page":"40699","DOI":"10.1038\/srep40699","article-title":"DOPAL derived alpha-synuclein oligomers impair synaptic vesicles physiological function","volume":"7","author":"Plotegher","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2026.119534_bib80","doi-asserted-by":"crossref","first-page":"7374","DOI":"10.1002\/anie.201600277","article-title":"Toxic Dopamine Metabolite DOPAL forms an unexpected dicatechol pyrrole adduct with lysines of \u03b1-synuclein","volume":"55","author":"Werner-Allen","year":"2016","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.biopha.2026.119534_bib81","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.neulet.2005.11.068","article-title":"Positive immunoreactivity for vesicular monoamine transporter 2 in Lewy bodies and Lewy neurites in substantia nigra","volume":"396","author":"Yamamoto","year":"2006","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.biopha.2026.119534_bib82","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s00401-012-0963-y","article-title":"Nigrostriatal overabundance of \u03b1-synuclein leads to decreased vesicle density and deficits in dopamine release that correlate with reduced motor activity","volume":"123","author":"Gaugler","year":"2012","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.biopha.2026.119534_bib83","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s10571-007-9227-0","article-title":"Inhibition of vesicular monoamine transporter-2 activity in \u03b1-synuclein stably transfected SH-SY5Y Cells","volume":"28","author":"Guo","year":"2008","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.biopha.2026.119534_bib84","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1038\/s41418-023-01187-0","article-title":"Identity, structure, and function of the mitochondrial permeability transition pore: controversies, consensus, recent advances, and future directions","volume":"30","author":"Bernardi","year":"2023","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.biopha.2026.119534_bib85","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0006-8993(03)03354-7","article-title":"3,4-Dihydroxyphenylacetaldehyde is the toxic dopamine metabolite in vivo: implications for Parkinson\u2019s disease pathogenesis","volume":"989","author":"Burke","year":"2003","journal-title":"Brain Res."},{"key":"10.1016\/j.biopha.2026.119534_bib86","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/S0891-5849(01)00484-1","article-title":"Selective dopaminergic vulnerability: 3,4-dihydroxyphenylacetaldehyde targets mitochondria","volume":"30","author":"Kristal","year":"2001","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.biopha.2026.119534_bib87","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1478-811X-11-34","article-title":"Complexity of dopamine metabolism","volume":"11","author":"Meiser","year":"2013","journal-title":"Cell Commun. Signal"},{"key":"10.1016\/j.biopha.2026.119534_bib88","doi-asserted-by":"crossref","DOI":"10.1016\/j.clineuro.2024.108189","article-title":"Effectiveness and safety of different catechol-o-methyl transferase inhibitors for patients with parkinson\u2019s disease: Systematic review and network meta-analysis","volume":"239","author":"Wu","year":"2024","journal-title":"Clin. Neurol. Neurosurg."},{"key":"10.1016\/j.biopha.2026.119534_bib89","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103418","article-title":"Neurological and psychiatric management using COMT inhibitors: a review","volume":"94","author":"Akhtar","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.biopha.2026.119534_bib90","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.parkreldis.2008.10.001","article-title":"Correlation between changes in CSF dopamine turnover and development of dyskinesia in Parkinson\u2019s disease","volume":"15","author":"Lunardi","year":"2009","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.biopha.2026.119534_bib91","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.neuint.2017.01.007","article-title":"Homovanillic acid in CSF of mild stage Parkinson\u2019s disease patients correlates with motor impairment","volume":"105","author":"Stefani","year":"2017","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.biopha.2026.119534_bib92","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s00259-019-04574-3","article-title":"From metabolic connectivity to molecular connectivity: application to dopaminergic pathways","volume":"47","author":"Verger","year":"2020","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.biopha.2026.119534_bib93","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.tins.2007.03.006","article-title":"Dopamine neuron systems in the brain: an update","volume":"30","author":"Bj\u00f6rklund","year":"2007","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.biopha.2026.119534_bib94","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/0166-2236(89)90074-X","article-title":"The functional anatomy of basal ganglia disorders","volume":"12","author":"Albin","year":"1989","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.biopha.2026.119534_bib95","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/nature18942","article-title":"Rapid signalling in distinct dopaminergic axons during locomotion and reward","volume":"535","author":"Howe","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2026.119534_bib96","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1016\/S1471-1931(00)00028-8","article-title":"Pathophysiology of the basal ganglia in Parkinson\u2019s disease","volume":"23","author":"Obeso","year":"2000","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.biopha.2026.119534_bib97","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.conb.2014.07.008","article-title":"Dopaminergic modulation of striatal networks in health and Parkinson\u2019s disease","volume":"29","author":"Surmeier","year":"2014","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.biopha.2026.119534_bib98","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.neuron.2013.05.014","article-title":"Differential innervation of direct- and indirect-pathway striatal projection neurons","volume":"79","author":"Wall","year":"2013","journal-title":"Neuron"},{"key":"10.1016\/j.biopha.2026.119534_bib99","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.cca.2021.08.009","article-title":"Dopamine in Parkinson\u2019s disease","volume":"522","author":"Latif","year":"2021","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.biopha.2026.119534_bib100","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0166-2236(90)90110-V","article-title":"Primate models of movement disorders of basal ganglia origin","volume":"13","author":"DeLong","year":"1990","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.biopha.2026.119534_bib101","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1152\/jn.1985.54.2.433","article-title":"Influence of the globus pallidus on arm movements in monkeys. III. Timing of movement-related information","volume":"54","author":"Anderson","year":"1985","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.biopha.2026.119534_bib102","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.cub.2020.11.019","article-title":"A disynaptic circuit in the Globus pallidus controls locomotion inhibition","volume":"31","author":"Aristieta","year":"2021","journal-title":"Curr. Biol."},{"key":"10.1016\/j.biopha.2026.119534_bib103","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0306-4522(82)90159-2","article-title":"Morphological and physiological properties of neostriatal neurons: an intracellular horseradish peroxidase study in the rat","volume":"7","author":"Bishop","year":"1982","journal-title":"Neuroscience"},{"key":"10.1016\/j.biopha.2026.119534_bib104","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0119152","article-title":"Dopaminergic Control of the Globus Pallidus through Activation of D2 receptors and its impact on the electrical activity of Subthalamic Nucleus and Substantia Nigra Reticulata Neurons","volume":"10","author":"Mamad","year":"2015","journal-title":"PLOS ONE"},{"key":"10.1016\/j.biopha.2026.119534_bib105","first-page":"4","article-title":"Convergence of dopamine and glutamate signaling onto striatal ERK activation in response to drugs of abuse","author":"Cahill","year":"2014","journal-title":"Front. Pharm."},{"key":"10.1016\/j.biopha.2026.119534_bib106","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1007\/s00381-002-0604-1","article-title":"Functional anatomy of thalamus and basal ganglia","volume":"18","author":"Herrero","year":"2002","journal-title":"Childs Nerv. Syst."},{"key":"10.1016\/j.biopha.2026.119534_bib107","doi-asserted-by":"crossref","DOI":"10.3389\/fncir.2021.645287","article-title":"Connectivity and functionality of the globus pallidus externa under normal conditions and Parkinson\u2019s Disease","volume":"15","author":"Dong","year":"2021","journal-title":"Front. Neural Circuits"},{"key":"10.1016\/j.biopha.2026.119534_bib108","doi-asserted-by":"crossref","first-page":"S237","DOI":"10.1016\/S1353-8020(09)70822-3","article-title":"Update on models of basal ganglia function and dysfunction","volume":"15","author":"DeLong","year":"2009","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.biopha.2026.119534_bib109","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s00401-010-0711-0","article-title":"The synaptic pathology of \u03b1-synuclein aggregation in dementia with Lewy bodies, Parkinson\u2019s disease and Parkinson\u2019s disease dementia","volume":"120","author":"Schulz-Schaeffer","year":"2010","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.biopha.2026.119534_bib110","doi-asserted-by":"crossref","first-page":"80","DOI":"10.3389\/fnins.2018.00080","article-title":"Mechanisms of \u03b1-Synuclein Induced Synaptopathy in Parkinson\u2019s Disease","volume":"12","author":"Bridi","year":"2018","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.biopha.2026.119534_bib111","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/ana.21995","article-title":"Clinical progression in Parkinson disease and the neurobiology of axons","volume":"67","author":"Cheng","year":"2010","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.biopha.2026.119534_bib112","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1093\/brain\/awt192","article-title":"Disease duration and the integrity of the nigrostriatal system in Parkinson\u2019s disease","volume":"136","author":"Kordower","year":"2013","journal-title":"Brain"},{"key":"10.1016\/j.biopha.2026.119534_bib113","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1523\/JNEUROSCI.4029-08.2009","article-title":"Single Nigrostriatal Dopaminergic Neurons Form Widely Spread and Highly Dense Axonal Arborizations in the Neostriatum","volume":"29","author":"Matsuda","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.biopha.2026.119534_bib114","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1016\/j.cub.2015.07.050","article-title":"Elevated Mitochondrial Bioenergetics and Axonal Arborization Size Are Key Contributors to the Vulnerability of Dopamine Neurons","volume":"25","author":"Pacelli","year":"2015","journal-title":"Curr. Biol."},{"key":"10.1016\/j.biopha.2026.119534_bib115","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1002\/mds.25135","article-title":"Living on the edge with too many mouths to feed: Why dopamine neurons die","volume":"27","author":"Bolam","year":"2012","journal-title":"Mov. Disord."},{"key":"10.1016\/j.biopha.2026.119534_bib116","first-page":"7","article-title":"The energy cost of action potential propagation in dopamine neurons: clues to susceptibility in Parkinson\u2019s disease","author":"Pissadaki","year":"2013","journal-title":"Front. Comput. Neurosci."},{"key":"10.1016\/j.biopha.2026.119534_bib117","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ceca.2009.12.003","article-title":"Calcium, cellular aging, and selective neuronal vulnerability in Parkinson\u2019s disease","volume":"47","author":"Surmeier","year":"2010","journal-title":"Cell Calcium"},{"key":"10.1016\/j.biopha.2026.119534_bib118","doi-asserted-by":"crossref","first-page":"11024","DOI":"10.1073\/pnas.191352298","article-title":"Calcium regulation of neuronal gene expression","volume":"98","author":"West","year":"2001","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.biopha.2026.119534_bib119","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1089\/ars.2010.3386","article-title":"Neuronal Calcium Homeostasis and Dysregulation","volume":"14","author":"Gleichmann","year":"2011","journal-title":"Antioxid. Redox Signal"},{"key":"10.1016\/j.biopha.2026.119534_bib120","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a009290","article-title":"Physiological Phenotype and Vulnerability in Parkinson\u2019s Disease","volume":"2","author":"Surmeier","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.biopha.2026.119534_bib121","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0306-4522(83)90135-5","article-title":"Intracellular and extracellular electrophysiology of nigral dopaminergic neurons-1. Identification and characterization","volume":"10","author":"Grace","year":"1983","journal-title":"Neuroscience"},{"key":"10.1016\/j.biopha.2026.119534_bib122","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1523\/JNEUROSCI.4341-06.2007","article-title":"Roles of subthreshold calcium current and sodium current in spontaneous firing of mouse midbrain dopamine neurons","volume":"27","author":"Puopolo","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.biopha.2026.119534_bib123","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/366156a0","article-title":"Different types of calcium channels mediate central synaptic transmission","volume":"366","author":"Takahashi","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2026.119534_bib124","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3389\/fnmol.2019.00055","article-title":"Calcium, Dopamine and neuronal calcium sensor 1: their contribution to Parkinson\u2019s Disease","volume":"12","author":"Catoni","year":"2019","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.biopha.2026.119534_bib125","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1038\/nature09536","article-title":"Oxidant stress evoked by pacemaking in dopaminergic neurons is attenuated by DJ-1","volume":"468","author":"Guzman","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2026.119534_bib126","doi-asserted-by":"crossref","first-page":"7401","DOI":"10.1523\/JNEUROSCI.0143-10.2010","article-title":"Pacemaking in dopaminergic ventral tegmental area neurons: depolarizing drive from background and voltage-dependent sodium conductances","volume":"30","author":"Khaliq","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.biopha.2026.119534_bib127","first-page":"8","article-title":"Calbindin content and differential vulnerability of midbrain efferent dopaminergic neurons in macaques","author":"Dopeso-Reyes","year":"2014","journal-title":"Front. Neuroanat."},{"key":"10.1016\/j.biopha.2026.119534_bib128","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.expneurol.2006.08.015","article-title":"Mitochondria mass is low in mouse substantia nigra dopamine neurons: Implications for Parkinson\u2019s disease","volume":"203","author":"Liang","year":"2007","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.biopha.2026.119534_bib129","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a011353","article-title":"Calcium Control of Neurotransmitter Release","volume":"4","author":"Sudhof","year":"2012","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.biopha.2026.119534_bib130","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.neuroscience.2011.08.066","article-title":"Dopamine release in the basal ganglia","volume":"198","author":"Rice","year":"2011","journal-title":"Neuroscience"},{"key":"10.1016\/j.biopha.2026.119534_bib131","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0306-4522(91)90196-U","article-title":"Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: A hypothesis for the etiology of schizophrenia","volume":"41","author":"Grace","year":"1991","journal-title":"Neuroscience"},{"key":"10.1016\/j.biopha.2026.119534_bib132","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.tins.2007.03.003","article-title":"Regulation of firing of dopaminergic neurons and control of goal-directed behaviors","volume":"30","author":"Grace","year":"2007","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.biopha.2026.119534_bib133","doi-asserted-by":"crossref","first-page":"14273","DOI":"10.1523\/JNEUROSCI.1894-10.2010","article-title":"Influence of Phasic and Tonic Dopamine Release on Receptor Activation","volume":"30","author":"Dreyer","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.biopha.2026.119534_bib134","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/j.neuron.2015.08.027","article-title":"RIM-BPs Mediate Tight Coupling of Action Potentials to Ca 2+ -Triggered Neurotransmitter Release","volume":"87","author":"Acuna","year":"2015","journal-title":"Neuron"},{"key":"10.1016\/j.biopha.2026.119534_bib135","article-title":"The role of RIM in neurotransmitter release: promotion of synaptic vesicle docking, priming, and fusion","volume":"17","author":"Wu","year":"2023","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.biopha.2026.119534_bib136","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.neuron.2010.12.014","article-title":"RIM Determines Ca2+ Channel Density and Vesicle Docking at the Presynaptic Active Zone","volume":"69","author":"Han","year":"2011","journal-title":"Neuron"},{"key":"10.1016\/j.biopha.2026.119534_bib137","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1146\/annurev.neuro.28.061604.135722","article-title":"Multiple dopamine functions at different time courses","volume":"30","author":"Schultz","year":"2007","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.biopha.2026.119534_bib138","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1152\/jn.1998.80.1.1","article-title":"Predictive reward signal of dopamine neurons","volume":"80","author":"Schultz","year":"1998","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.biopha.2026.119534_bib139","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.tins.2004.10.001","article-title":"Dopamine: the salient issue","volume":"27","author":"Ungless","year":"2004","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.biopha.2026.119534_bib140","doi-asserted-by":"crossref","first-page":"3980","DOI":"10.1016\/j.neuron.2021.09.054","article-title":"Munc13-1 is a Ca2+-phospholipid-dependent vesicle priming hub that shapes synaptic short-term plasticity and enables sustained neurotransmission","volume":"109","author":"Lipstein","year":"2021","journal-title":"Neuron"},{"key":"10.1016\/j.biopha.2026.119534_bib141","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.neuron.2010.10.026","article-title":"Bassoon Speeds Vesicle Reloading at a Central Excitatory Synapse","volume":"68","author":"Hallermann","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.biopha.2026.119534_bib142","doi-asserted-by":"crossref","first-page":"56","DOI":"10.3389\/fnmol.2019.00056","article-title":"Emerging Roles of Neuronal Ca2+ Sensor-1 in Cardiac and Neuronal Tissues: A Mini Review","volume":"12","author":"Nakamura","year":"2019","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.biopha.2026.119534_bib143","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.conb.2019.01.001","article-title":"Mechanisms and regulation of dopamine release","volume":"57","author":"Liu","year":"2019","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.biopha.2026.119534_bib144","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.neuron.2019.09.015","article-title":"The RAB3-RIM Pathway Is Essential for the Release of Neuromodulators","volume":"104","author":"Persoon","year":"2019","journal-title":"Neuron"},{"key":"10.1016\/j.biopha.2026.119534_bib145","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.107960","article-title":"A Trio of Active Zone Proteins Comprised of RIM-BPs, RIMs, and Munc13s Governs Neurotransmitter Release","volume":"32","author":"Brockmann","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.biopha.2026.119534_bib146","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.conb.2020.03.008","article-title":"Assembly of the presynaptic active zone","volume":"63","author":"Emperador-Melero","year":"2020","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.biopha.2026.119534_bib147","doi-asserted-by":"crossref","first-page":"RP88412","DOI":"10.7554\/eLife.88412.3","article-title":"Ca2+ channel and active zone protein abundance intersects with input-specific synapse organization to shape functional synaptic diversity","volume":"12","author":"Medeiros","year":"2024","journal-title":"eLife"},{"key":"10.1016\/j.biopha.2026.119534_bib148","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.cell.2018.01.008","article-title":"Dopamine Secretion Is Mediated by Sparse Active Zone-like Release Sites","volume":"172","author":"Liu","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2026.119534_bib149","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.1038\/s41467-021-23116-w","article-title":"PKC-phosphorylation of Liprin-\u03b13 triggers phase separation and controls presynaptic active zone structure","volume":"12","author":"Emperador-Melero","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2026.119534_bib150","doi-asserted-by":"crossref","first-page":"6504","DOI":"10.1073\/pnas.1002307107","article-title":"Piccolo and bassoon maintain synaptic vesicle clustering without directly participating in vesicle exocytosis","volume":"107","author":"Mukherjee","year":"2010","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.biopha.2026.119534_bib151","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/S0896-6273(03)00088-6","article-title":"Functional Inactivation of a Fraction of Excitatory Synapses in Mice Deficient for the Active Zone Protein Bassoon","volume":"37","author":"Altrock","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.biopha.2026.119534_bib152","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0896-6273(01)00272-0","article-title":"Functional Interaction of the Active Zone Proteins Munc13-1 and RIM1 in Synaptic Vesicle Priming","volume":"30","author":"Betz","year":"2001","journal-title":"Neuron"},{"key":"10.1016\/j.biopha.2026.119534_bib153","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.neuron.2011.01.005","article-title":"RIM Proteins Activate Vesicle Priming by Reversing Autoinhibitory Homodimerization of Munc13","volume":"69","author":"Deng","year":"2011","journal-title":"Neuron"},{"key":"10.1016\/j.biopha.2026.119534_bib154","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1038\/sj.emboj.7600753","article-title":"A Munc13\/RIM\/Rab3 tripartite complex: from priming to plasticity","volume":"24","author":"Dulubova","year":"2005","journal-title":"EMBO J."},{"key":"10.1016\/j.biopha.2026.119534_bib155","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S0896-6273(02)00667-0","article-title":"RIM Binding Proteins (RBPs) Couple Rab3-Interacting Molecules (RIMs) to Voltage-Gated Ca2+ Channels","volume":"34","author":"Hibino","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.biopha.2026.119534_bib156","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.cell.2010.12.029","article-title":"RIM Proteins Tether Ca2+ Channels to Presynaptic Active Zones via a Direct PDZ-Domain Interaction","volume":"144","author":"Kaeser","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2026.119534_bib157","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.neuron.2016.07.042","article-title":"How to Make an Active Zone: Unexpected Universal Functional Redundancy between RIMs and RIM-BPs","volume":"91","author":"Acuna","year":"2016","journal-title":"Neuron"},{"key":"10.1016\/j.biopha.2026.119534_bib158","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/22768","article-title":"Munc13-1 is essential for fusion competence of glutamatergic synaptic vesicles","volume":"400","author":"Augustin","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2026.119534_bib159","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/S0140-6736(25)01072-4","article-title":"Vesicular monoamine transport inhibitors: current uses and future directions","volume":"406","author":"Rosenthal","year":"2025","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2026.119534_bib160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1092852917000621","article-title":"Mechanism of action of vesicular monoamine transporter 2 (VMAT2) inhibitors in tardive dyskinesia: reducing dopamine leads to less \u201cgo\u201d and more \u201cstop\u201d from the motor striatum for robust therapeutic effects","volume":"23","author":"Stahl","year":"2018","journal-title":"CNS Spectr."},{"key":"10.1016\/j.biopha.2026.119534_bib161","doi-asserted-by":"crossref","DOI":"10.3389\/fnbeh.2020.578443","article-title":"Selective Knockout of the Vesicular Monoamine Transporter 2 (Vmat2) Gene in Calbindin2\/Calretinin-Positive Neurons Results in Profound Changes in Behavior and Response to Drugs of Abuse","volume":"14","author":"K\u00f6nig","year":"2020","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.biopha.2026.119534_bib162","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.neuron.2012.06.012","article-title":"The Presynaptic Active Zone","volume":"75","author":"S\u00fcdhof","year":"2012","journal-title":"Neuron"},{"key":"10.1016\/j.biopha.2026.119534_bib163","first-page":"8","article-title":"Synaptic Vesicle Proteins and Active Zone Plasticity","author":"Kittel","year":"2016","journal-title":"Front. Synaptic Neurosci."},{"key":"10.1016\/j.biopha.2026.119534_bib164","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1172\/JCI95898","article-title":"Systemic isradipine treatment diminishes calcium-dependent mitochondrial oxidant stress","volume":"128","author":"Guzman","year":"2018","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.biopha.2026.119534_bib165","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/mds.28850","article-title":"Re-Analysis of the STEADY-PD II Trial\u2014Evidence for Slowing the Progression of Parkinson\u2019s Disease","volume":"37","author":"Surmeier","year":"2022","journal-title":"Mov. Disord."},{"key":"10.1016\/j.biopha.2026.119534_bib166","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1002\/acn3.51300","article-title":"Isradipine plasma pharmacokinetics and exposure\u2013response in early Parkinson\u2019s disease","volume":"8","author":"Venuto","year":"2021","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.biopha.2026.119534_bib167","doi-asserted-by":"crossref","first-page":"591","DOI":"10.7326\/M19-2534","article-title":"A Randomized Trial","volume":"172","author":"Isradipine Versus Placebo in Early Parkinson Disease","year":"2020","journal-title":"Ann. Intern. Med"},{"key":"10.1016\/j.biopha.2026.119534_bib168","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2174\/1568007033482913","article-title":"3,4-Dihydroxyphenylacetaldehyde: a potential target for neuroprotective therapy in Parkinsons Disease","volume":"2","author":"Burke","year":"2003","journal-title":"Curr. Drug Target -CNS Neurol. Disord."},{"key":"10.1016\/j.biopha.2026.119534_bib169","doi-asserted-by":"crossref","DOI":"10.1016\/j.dscb.2024.100163","article-title":"Novel approaches targeting \u03b1-Synuclein for Parkinson\u2019s Disease: current progress and future directions for the disease-modifying therapies","volume":"16","author":"Baggett","year":"2024","journal-title":"Brain Disord."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226005706?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226005706?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T22:45:17Z","timestamp":1787438717000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332226005706"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":169,"alternative-id":["S0753332226005706"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119534","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Distinctive characteristics of dopamine neuron release mechanisms: Insights into Parkinson\u2019s Disease","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119534","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"119534"}}